CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
OZ439drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02453581
NCT02453581Phase 1Completed
CompareCT.gov

An Experimental Study To Characterize the Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection In Healthy Volunteers

Medicines for Malaria Venture·interventional·Posted May 25, 2015·Updated Aug 17, 2015

In Brief

A Phase 1 clinical trial evaluating OZ439 for Malaria. Completed, enrolled 24 participants across 1 site.

Detailed Summary

A single centre, open, controlled study using Blood Stage Plasmodium falciparum challenge inoculum (BSPC) as a model to assess the effectiveness of three dose levels of the experimental anti-malarial product, OZ439.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria
CountriesAustralia
CollaboratorsQueensland Institute of Medical Research

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 25, 2015
Enrollment StartSep 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.1 years ago

Interventions

OZ439drug

OZ439 Powder for Oral Suspension